Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 23.42M P/E - EPS this Y - Ern Qtrly Grth -
Income -14.82M Forward P/E -7.08 EPS next Y - 50D Avg Chg -9.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -8.00%
Dividend N/A Price/Book 0.62 EPS next 5Y - 52W High Chg -17.00%
Recommedations 3.00 Quick Ratio 27.21 Shares Outstanding 8.46M 52W Low Chg 15.00%
Insider Own 8.24% ROA -5.24% Shares Float 8.06M Beta -0.20
Inst Own 15.07% ROE -1.74% Shares Shorted/Prior 7.62K/25.36K Price 2.69
Gross Margin - Profit Margin - Avg. Volume 51,738 Target Price -
Oper. Margin - Earnings Date Mar 15 Volume 12,089 Change 0.75%
About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

PMCB Chatroom

User Image WallStreetBetzz Posted - 1 day ago

$PMCB $FEMY What y'all think about this bet? 🦍🟢🥗🥗

User Image TheStocksGoose Posted - 2 days ago

$SLS reminds me of $PMCB. Just an absolute scam

User Image NEWBIGTECH Posted - 2 days ago

$PMCB Doubled our watchers from Monday last week. Pick just keeps going up as $femy moves sideways with their great results for their alternative to ivf.

User Image NEWBIGTECH Posted - 1 week ago

$PMCB $FEMY

User Image NEWBIGTECH Posted - 1 week ago

$FEMY $PMCB is up again today, on femy'$ good news. $2.45. since the news announcement it is up .47 cents.

User Image D6975 Posted - 1 week ago

$PMCB maybe time to start lowering my cost average here and buy more.

User Image NEWBIGTECH Posted - 1 week ago

$PMCB stock should show life after $FEMY news . I hope cell in the box takes off. I have been in forever. 2 reverse splits.

User Image NEWBIGTECH Posted - 1 week ago

$PMCB So the investment in $FEMY WILL PAY OFF FOR PMCB. GREAT NEWS for femysys. https://www.biospace.com/article/releases/femasys-announces-positive-topline-data-from-pivotal-trial-for-its-fda-cleared-femaseed-for-the-treatment-of-infertility/

User Image Pistol_Pete_P Posted - 1 week ago

$PMCB is this scam still alive?

User Image NEWBIGTECH Posted - 2 weeks ago

@stoneblood see the financing by $PMCB . There agreement to use femy's device for cell in the box.

User Image NEWBIGTECH Posted - 2 weeks ago

$PMCB it appears that punch has hitched their wagon to $FEMY , with the $7 mil loan and cell in the box, through astrianova . So I guess they are sitting and waiting for sales from both. I do suspect that $PMCB will use the census injection system for cell in a box. Linking the two looks like a good solution. Win, win for all. Just my opinion. G LTA .

User Image NEWBIGTECH Posted - 2 weeks ago

$PMCB This I found But, check out the dates???? PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q2 2024 PharmaCyte Biotech just reported results for the second quarter of 2024 By InvestorPlace Earnings Dec 18, 2023, 11:51 am EDT PharmaCyte Biotech (NASDAQ:PMCB) just reported results for the second quarter of 2024. PharmaCyte Biotech reported earnings per share of -26 cents. The company did not report any revenue for the quarter. https://investorplace.com/earning-results/2023/12/pmcb-stock-earnings-pharmacyte-biotech-for-q2-of-2024/

User Image NEWBIGTECH Posted - 2 weeks ago

$PMCB last info. "PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) provides an update on its investigation of its Cell-in-a-Box technology and initial next steps in development. Following a comprehensive scientific review of amassed data, the Company is in the process of requesting a meeting with the U.S. Food and Drug Administration (FDA) for guidance on further development of the technology. The meeting is expected to occur during the first quarter of 2024. In the meantime, the Company is reviewing multiple potential opportunities that it believes would be prudent uses for its approximately $74.6 million cash position as of July 31, 2023, which was previously reported in the Company’s Quarterly Report on Form 10-Q filed on September 18, 2023." https://www.businesswire.com/news/home/20231031782802/en/PharmaCyte-Biotech-Provides-Corporate-Update-on-Cell-in-a-Box-Technology

User Image NEWBIGTECH Posted - 2 weeks ago

$PMCB DAMN.. What's going on with this company? They loan money to FEMY and then just fade away. What's going on with Cell in a box? What are they working on?

User Image Nu2thegame Posted - 3 weeks ago

$PMCB has two employees. Cmon ppl

User Image NEWBIGTECH Posted - 1 month ago

$PMCB Here are the Institutional owners. $BLK $VTI

User Image Pistol_Pete_P Posted - 1 month ago

$PMCB scam and buyers be aware

User Image NEWBIGTECH Posted - 1 month ago

$PMCB Must be news.

User Image STOCKTWITS_SCAMS_U Posted - 1 month ago

$PMCB

User Image NEWBIGTECH Posted - 01/30/24

$PMCB There was a Huge Drop in Short Interest in PMCB. Probably because it never moves.

User Image NEWBIGTECH Posted - 01/30/24

$PMCB Not many Watchers. 5912 .

User Image tickeron Posted - 2 months ago

A.I.dvisor made a bullish call on $PMCB, netting in a 4.10% gain over 1 day https://srnk.us/go/4976031

User Image Kanate123 Posted - 2 months ago

$PMCB ELDN was a 2000.00 stock according to the charts. If i am correct Cantor has a price target of 8.00 and others 17.00 Largest shareholders include Bvf Inc/il, Armistice Capital, Llc, Vanguard Group Inc, Woodline Partners LP, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Ensign Peak Advisors, Inc, CM Management, LLC, VEXMX - Vanguard Extended Market Index Fund Investor Shares, Geode Capital Management, Llc, and Royal Bank Of Canada .This is huge if they get FDA approval . Nothing is a guarantee but this is worth a try

User Image tickeron Posted - 12/31/23

This is amazing! What do you think? $PMCB price exceeded its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4956151

User Image tickeron Posted - 3 months ago

Does this make you nervous? $PMCB entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4952952

User Image tickeron Posted - 3 months ago

PharmaCyte Biotech to report earnings on June 28, 2023. Earnings per share (EPS) estimate: $-0.09 $PMCB https://srnk.us/go/4949847

User Image tickeron Posted - 3 months ago

PharmaCyte Biotech to report earnings on June 28, 2023. Earnings per share (EPS) estimate: $-0.09 $PMCB https://srnk.us/go/4944140

User Image tickeron Posted - 3 months ago

This is amazing! What do you think? $PMCB MACD Histogram turned negative on December 15, 2023. View odds of downtrend. https://srnk.us/go/4943235

User Image Last10K Posted - 3 months ago

$PMCB just filed a 10-Q Quarterly Report with 8 financial statements and 38 disclosures: https://last10k.com/sec-filings/pmcb/0001683168-23-008889.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=pmcb

User Image risenhoover Posted - 3 months ago

$PMCB / PharmaCyte Biotech files form 10-Q https://fintel.io/doc/sec-pharmacyte-biotech-inc-1157075-10q-2023-december-15-19706-5324?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
HC Wainwright & Co. Neutral Nov 8, 21